Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending September 4, 2003. The report details a specific corporate action regarding share repurchases authorized by shareholders at the Annual General Meeting on May 19, 2003.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to a specific share buyback transaction:
- Shares Purchased: 800,000 ordinary shares
- Purchase Date: September 3, 2003
- Price Per Share: 1,241.96p
- Transaction Purpose: Cancellation of shares
Material Changes
The filing does not report material changes in operating results or financial position compared to prior periods. The primary change reported is the reduction of the company's share capital through the cancellation of 800,000 shares.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, outlook, risk factors, or contingencies. It is a procedural report confirming the execution of a previously authorized share buyback.
Key Facts for Investor Verification
- Verify the total number of shares repurchased and cancelled to date under the May 19, 2003 authorization.
- Confirm the impact of this specific buyback on the company's total outstanding share count.
- Note that this filing does not contain quarterly or annual financial performance data.